In a major shift for the UK’s healthcare system, every newborn baby will soon have their DNA tested under a bold new 10-year plan to modernise the NHS.
The initiative, set to launch as part of the upcoming Life Sciences Sector Plan in July, will use whole-genome sequencing to screen for hundreds of genetic diseases from birth. The goal? To move the NHS away from just treating illness and toward preventing it altogether.
Health Secretary Wes Streeting unveiled the plan, calling it a leap forward in personalised medicine. “The revolution in medical science means we can transform the NHS from a service that diagnoses and treats illness to one that predicts and prevents it,” he said in a statement to The Telegraph.
As part of this transformation, the government has pledged £650 million to genomics research, and will also harness technologies like artificial intelligence to help doctors detect illnesses earlier and offer personalised treatments—potentially even before symptoms appear.
Currently, newborns in the UK are screened using a blood spot test (commonly known as the “heel prick”), which checks for just nine rare but serious conditions. Under the new system, blood will likely be collected from the umbilical cord right after birth, enabling a full genetic analysis.
Streeting stressed that this shift is not only about improving care but also easing pressure on NHS services by tackling disease before it develops. “Genomics gives us the opportunity to leapfrog disease, so we’re ahead of it rather than reacting to it,” he said.
The 10-year plan includes two other major reforms:
- Moving more care out of hospitals and into local communities
- Transitioning from analogue systems to digital services
This vision of a high-tech, prevention-first NHS also follows Chancellor Rachel Reeves’ announcement that the government will boost NHS funding by £29 billion per year in real terms over the next three years. It’s part of a broader effort to cut waiting lists and fulfill key election promises.
If successful, the plan could mark a turning point for public health in the UK, offering future generations longer, healthier lives—starting from the day they’re born.
